Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer

Published:2019-07-15 Issue:3 Volume:51 Page:1117-1127
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Li Lan Ying,Kim Hee Jung,Park Sun Ae,Lee So Hyun,Kim Lee Kyung,Lee Jung Yun,Kim Sunghoon,Kim Young Tae,Kim Sang Wun,Nam Eun Ji

Funder

Korea Health Industry Development Institute

Ministry of Health and Welfare

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Yonsei University College of Medicine

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-405.pdf

Reference29 articles.

1. Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy

2. The problem with platinum

3. Drug Resistance and the Solid Tumor Microenvironment

4. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer

5. Whole–genome characterization of chemoresistant ovarian cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors;Cells;2024-05-17

2. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience;Journal of Clinical Medicine;2024-05-06

3. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03

4. Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer;Current Oncology;2023-12-29

5. Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer—The Possibility or the Necessity?;Journal of Personalized Medicine;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3